Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.

A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Tuberculosis (TB) remains the world's leading cause of death from a single infectious agent. A new study recently published in The Lancet Global Health and supported by the World Health Organization ...

A tuberculosis case at a Georgia Army post exposed dozens of trainees to latent infection, highlighting risks in close ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

New research from Imperial College London suggests that infection with the influenza virus may leave people more susceptible ...

BIRMINGHAM, Ala. – University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency ...

Add Yahoo as a preferred source to see more of our stories on Google. Tuberculosis is making headlines as the contagious respiratory disease spreads in the Midwest. Kansas is currently facing one of ...

Tuberculosis (TB) can transmit via the air, and the risk of infection depends on several factors. These can include the duration of exposure, proximity to a person with the infection, and immune ...

A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone in preventing tuberculosis (TB) in people with ...